{"id":"cerivastatin","rwe":[{"pmid":"41901325","year":"2026","title":"Something Old Brings New Insights: Activity of Cerivastatin Against Thermally Dimorphic Fungi and Its Potential as an Antifungal Scaffold.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41674924","year":"2026","title":"Causal Association Between Plasma Proteins and Pericarditis: A Mendelian Randomization Study With Therapeutic Target Identification.","finding":"","journal":"Mediators of inflammation","studyType":"Clinical Study"},{"pmid":"41670022","year":"2026","title":"In Vitro and In Vivo Evaluation of Polycaprolactone/Carboxymethyl Chitosan Composite 3D Scaffolds Loaded With Cerivastatin and 45S5 Bioglass Nanoparticles for Bone Tissue Engineering in Rat Calvarial Defects.","finding":"","journal":"Journal of biomedical materials research. Part B, Applied biomaterials","studyType":"Clinical Study"},{"pmid":"41217343","year":"2026","title":"Integrated multi-omics and molecular docking reveal shared molecular mechanisms of Helicobacter pylori infection and rheumatic diseases.","finding":"","journal":"International journal of surgery (London, England)","studyType":"Clinical Study"},{"pmid":"41199297","year":"2025","title":"Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer.","finding":"","journal":"Journal of ovarian research","studyType":"Clinical Study"}],"tags":[{"label":"cerivastatin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","category":"target"},{"label":"HMGCR","category":"gene"},{"label":"NR1I3","category":"gene"},{"label":"C10AA06","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Hypercholesterolemia","category":"indication"},{"label":"Mixed hyperlipidemia","category":"indication"},{"label":"Bayer Pharms","category":"company"},{"label":"Approved 1990s","category":"decade"},{"label":"Anticholesteremic Agents","category":"pharmacology"},{"label":"Antimetabolites","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","category":"pharmacology"},{"label":"Hypolipidemic Agents","category":"pharmacology"},{"label":"Lipid Regulating Agents","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/ciclosporin","drug":"ciclosporin","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Cyclosporine","source":"DrugCentral","drugSlug":"ciclosporin"},{"url":"/drug/clarithromycin","drug":"clarithromycin","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Clarithromycin","source":"DrugCentral","drugSlug":"clarithromycin"},{"url":"/drug/erythromycin","drug":"erythromycin","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Erythromycin","source":"DrugCentral","drugSlug":"erythromycin"},{"url":"/drug/fosamprenavir","drug":"fosamprenavir","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Fosamprenavir","source":"DrugCentral","drugSlug":"fosamprenavir"},{"url":"/drug/gemfibrozil","drug":"gemfibrozil","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Gemfibrozil","source":"DrugCentral","drugSlug":"gemfibrozil"},{"url":"/drug/indinavir","drug":"indinavir","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Indinavir Sulfate","source":"DrugCentral","drugSlug":"indinavir"},{"url":"/drug/itraconazole","drug":"itraconazole","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Itraconazole","source":"DrugCentral","drugSlug":"itraconazole"},{"url":"/drug/nefazodone","drug":"nefazodone","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Nefazodone","source":"DrugCentral","drugSlug":"nefazodone"},{"url":"/drug/nelfinavir","drug":"nelfinavir","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Nelfinavir Mesylate","source":"DrugCentral","drugSlug":"nelfinavir"},{"url":"/drug/nicotinic-acid","drug":"nicotinic acid","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Niacin","source":"DrugCentral","drugSlug":"nicotinic-acid"},{"url":"/drug/rifabutin","drug":"rifabutin","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Rifabutin","source":"DrugCentral","drugSlug":"rifabutin"},{"url":"/drug/ritonavir","drug":"ritonavir","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Ritonavir","source":"DrugCentral","drugSlug":"ritonavir"},{"url":"/drug/saquinavir","drug":"saquinavir","action":"Monitor closely","effect":"May interact with Cerivastatin Sodium, Saquinavir","source":"DrugCentral","drugSlug":"saquinavir"},{"url":"/drug/troleandomycin","drug":"troleandomycin","action":"Avoid combination","effect":"May interact with Cerivastatin Sodium, Troleandomycin","source":"DrugCentral","drugSlug":"troleandomycin"}],"contraindications":["Breastfeeding (mother)","Disease of liver","Hemorrhagic cerebral infarction","Kidney disease","Pregnancy, function","Rhabdomyolysis"]},"trials":[],"aliases":[],"company":"Bayer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CERIVASTATIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:46:22.353269+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:46:29.359458+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CERIVASTATIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:46:30.259211+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1477/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:46:30.765367+00:00"}},"allNames":"baycol","offLabel":[],"synonyms":["baycol","cerivastatin","baychol","cerivastatin sodium","cerivastatin sodium salt hydrate"],"timeline":[{"date":"1997-06-26","type":"positive","source":"DrugCentral","milestone":"FDA approval (Bayer Pharms)"}],"aiSummary":"Baycol, a small molecule, was studied for pain management in clinical trials, including a comparison of its analgesic effect in adductor canal block after total knee replacement using different administration methods.","approvals":[{"date":"1997-06-26","orphan":false,"company":"BAYER PHARMS","regulator":"FDA"}],"brandName":"Baycol","ecosystem":[{"indication":"Hypercholesterolemia","otherDrugs":[{"name":"alirocumab","slug":"alirocumab","company":"Sanofi Aventis"},{"name":"atorvastatin","slug":"atorvastatin","company":"Pfizer"},{"name":"cholestyramine","slug":"cholestyramine","company":"Bristol Myers"},{"name":"choline fenofibrate","slug":"choline-fenofibrate","company":"Abbvie"}],"globalPrevalence":390000000},{"indication":"Mixed hyperlipidemia","otherDrugs":[{"name":"atorvastatin","slug":"atorvastatin","company":"Pfizer"},{"name":"choline fenofibrate","slug":"choline-fenofibrate","company":"Abbvie"},{"name":"ezetimibe","slug":"ezetimibe","company":"Msd Intl Gmbh"},{"name":"fenofibrate","slug":"fenofibrate","company":"Abbvie"}],"globalPrevalence":390000000}],"mechanism":{"target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","novelty":"Follow-on","targets":[{"gene":"HMGCR","source":"DrugCentral","target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","protein":"3-hydroxy-3-methylglutaryl-coenzyme A reductase"},{"gene":"NR1I3","source":"DrugCentral","target":"Nuclear receptor subfamily 1 group I member 3","protein":"Nuclear receptor subfamily 1 group I member 3"}],"modality":"Small Molecule","drugClass":"cerivastatin","explanation":"","oneSentence":"","technicalDetail":"Cerivastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway, which is responsible for cholesterol biosynthesis in the liver."},"commercial":{"launchDate":"1997","_launchSource":"DrugCentral (FDA 1997-06-26, BAYER PHARMS)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/577","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CERIVASTATIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CERIVASTATIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T09:30:16.484823","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:46:32.754105+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"simvastatin","drugSlug":"simvastatin","fdaApproval":"1991-12-23","patentExpiry":"Feb 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"lovastatin","drugSlug":"lovastatin","fdaApproval":"1987-08-31","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"pravastatin","drugSlug":"pravastatin","fdaApproval":"1991-10-31","genericCount":16,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fluvastatin","drugSlug":"fluvastatin","fdaApproval":"1993-12-31","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"atorvastatin","drugSlug":"atorvastatin","fdaApproval":"1996-12-17","patentExpiry":"Jun 7, 2037","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"rosuvastatin","drugSlug":"rosuvastatin","fdaApproval":"2003-08-12","patentExpiry":"Feb 12, 2036","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"pitavastatin","drugSlug":"pitavastatin","fdaApproval":"2009-08-03","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"cerivastatin","indications":{"approved":[{"name":"Hypercholesterolemia","source":"DrugCentral","snomedId":13644009,"regulator":"FDA","usPrevalence":86000000,"globalPrevalence":390000000,"prevalenceMethod":"curated","prevalenceSource":"WHO Global Health Estimates, 2023"},{"name":"Mixed hyperlipidemia","source":"DrugCentral","snomedId":267434003,"regulator":"FDA","usPrevalence":null,"globalPrevalence":390000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"simvastatin","brandName":"simvastatin","genericName":"simvastatin","approvalYear":"1991","relationship":"same-class"},{"drugId":"lovastatin","brandName":"lovastatin","genericName":"lovastatin","approvalYear":"1987","relationship":"same-class"},{"drugId":"pravastatin","brandName":"pravastatin","genericName":"pravastatin","approvalYear":"1991","relationship":"same-class"},{"drugId":"fluvastatin","brandName":"fluvastatin","genericName":"fluvastatin","approvalYear":"1993","relationship":"same-class"},{"drugId":"atorvastatin","brandName":"atorvastatin","genericName":"atorvastatin","approvalYear":"1996","relationship":"same-class"},{"drugId":"rosuvastatin","brandName":"rosuvastatin","genericName":"rosuvastatin","approvalYear":"2003","relationship":"same-class"},{"drugId":"pitavastatin","brandName":"pitavastatin","genericName":"pitavastatin","approvalYear":"2009","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT03142789","phase":"PHASE4","title":"Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2017-05-09","conditions":["Pain Management"],"enrollment":153,"completionDate":"2018-04-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000148566","MMSL":"11450","NDDF":"006489","UNII":"AM91H2KS67","VUID":"4021111","CHEBI":"CHEBI:3558","VANDF":"4021111","INN_ID":"7083","RXNORM":"215567","UMLSCUI":"C0528023","chemblId":"CHEMBL1477","ChEMBL_ID":"CHEMBL1477","KEGG_DRUG":"D00889","DRUGBANK_ID":"DB00439","PDB_CHEM_ID":" 116","PUBCHEM_CID":"446156","SNOMEDCT_US":"108596008","IUPHAR_LIGAND_ID":"2950","SECONDARY_CAS_RN":"143201-11-0","MESH_SUPPLEMENTAL_RECORD_UI":"C086276"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1997-","companyName":"Bayer Pharms","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.8 hours","clearance":"2.9 mL/min/kg","bioavailability":"60%","fractionUnbound":"0.01%","volumeOfDistribution":"0.33 L/kg"},"publicationCount":698,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"C10AA06","allCodes":["C10AA06"]},"biosimilarFilings":[],"originalDeveloper":"Bayer Pharms","recentPublications":[{"date":"2026 Mar 14","pmid":"41901325","title":"Something Old Brings New Insights: Activity of Cerivastatin Against Thermally Dimorphic Fungi and Its Potential as an Antifungal Scaffold.","journal":"Pharmaceuticals (Basel, Switzerland)"},{"date":"2026","pmid":"41674924","title":"Causal Association Between Plasma Proteins and Pericarditis: A Mendelian Randomization Study With Therapeutic Target Identification.","journal":"Mediators of inflammation"},{"date":"2026 Feb","pmid":"41670022","title":"In Vitro and In Vivo Evaluation of Polycaprolactone/Carboxymethyl Chitosan Composite 3D Scaffolds Loaded With Cerivastatin and 45S5 Bioglass Nanoparticles for Bone Tissue Engineering in Rat Calvarial Defects.","journal":"Journal of biomedical materials research. Part B, Applied biomaterials"},{"date":"2026 Feb 1","pmid":"41217343","title":"Integrated multi-omics and molecular docking reveal shared molecular mechanisms of Helicobacter pylori infection and rheumatic diseases.","journal":"International journal of surgery (London, England)"},{"date":"2025 Nov 6","pmid":"41199297","title":"Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer.","journal":"Journal of ovarian research"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"withdrawn","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"1997","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1997-06-26T00:00:00.000Z","mah":"BAYER PHARMS","brand_name_local":null,"application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1997-06-26T00:00:00.000Z","mah":"BAYER PHARMS","brand_name_local":"BAYCOL","application_number":"NDA020740"},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:46:32.754105+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}